A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Will need to buy a company to enrich near-term pipeline outside of Xgeva/Prolia which won't contribute much to the bottom line for the next year or so... this will leave revenues flat. Entering "big pharma"-like phase... not a growth stock in the near term...